The latest update is out from SoftOx Solutions AS ( (DE:6FV) ).
SoftOx Solutions AS has resolved a legal dispute with a former consultant over a bonus claim for services rendered in 2022. The settlement involves an immediate payment of NOK 1.5 million and a deferred payment of NOK 0.8 million by June 2026, potentially impacting the company’s financials and stakeholder relations.
More about SoftOx Solutions AS
SoftOx Solutions AS is a pharmaceutical company listed on Euronext Growth Oslo, specializing in the development of antimicrobial solutions for biofilm, viral, and antimicrobial-resistant infections. Founded in 2012 and headquartered in Oslo, the company collaborates with leading Nordic research institutes to advance its patent-protected technology.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €6.1M
See more data about 6FV stock on TipRanks’ Stock Analysis page.